Get the latest tech news
The King of Ozempic Is Scared as Hell
Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?
So Novo assembled a new team of researchers that included Jesper Lau, a peptide and protein engineer, who invented sema glutide, from the French semaine, for “week.” Semaglutide suffuses the body and brain for seven days. Though many of us learned about PBMs only after the December assassination of Brian Thompson, the CEO of UnitedHealthcare, which is affiliated with a giant PBM, Jørgensen has called these middlemen the real enemy for a long time. Faced with having to ramp up production, feed lobbying and marketing divisions, and meet its earning projections, Novo Nordisk—the foundation-run, -conscience-stricken insulin company—seemed, from the outside, to be acting less like a research hospital and more like a corporation that had hit the heel of hockey-stick growth.
Or read this on Wired